Stereotaxis (STXS) Net Cash Flow Growth (1y) (2011 - 2026)
Stereotaxis (STXS) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -9.88% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 19.23% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -593.75% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -179.69% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 134.67% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -196.55% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -213.73% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 102.38% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 126.33% |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn | 168.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 168.40% |
| Dec 31, 2025 | 104.85% |
| Sep 30, 2025 | 185.26% |
| Jun 30, 2025 | -20.88% |
| Mar 31, 2025 | 24.57% |
| Dec 31, 2024 | 158.97% |
| Sep 30, 2024 | -336.03% |
| Jun 30, 2024 | -117.82% |
| Mar 31, 2024 | 25.17% |
| Dec 31, 2023 | 89.31% |
| Sep 30, 2023 | 64.61% |
| Jun 30, 2023 | 1,092.31% |
| Mar 31, 2023 | 6.01% |
| Dec 31, 2022 | -839.10% |
| Sep 30, 2022 | -95.92% |
| Jun 30, 2022 | -4,652.63% |
| Mar 31, 2022 | -5,677.19% |
| Dec 31, 2021 | -799.48% |
| Sep 30, 2021 | -234.61% |
| Jun 30, 2021 | -99.76% |